We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RATE
2176
DELISTED
Bankrate Inc
RATE
| $596K | ﹤0.01% |
61,720
+1,913
| +3% | +$20.7K |
|
2177
iShares Russell 2000 Value ETF
IWN
$14.3B
| $594K | ﹤0.01% |
+5,030
| New | +$597K |
|
|
KTWO
2178
DELISTED
K2M Group Holdings, Inc
KTWO
| $593K | ﹤0.01% |
28,924
+975
| +3% | +$20K |
|
2179
FIVE9
FIVN
$2.11B
| $591K | ﹤0.01% |
35,888
+677
| +2% | +$11.1K |
|
2180
Caesars Entertainment
CZR
$6.06B
| $590K | ﹤0.01% |
31,150
+1,116
| +4% | +$18.8K |
|
2181
First Hawaiian
FHB
$3.38B
| $582K | ﹤0.01% |
19,453
+1,608
| +9% | +$51.5K |
|
2182
York Water
YORW
$502M
| $580K | ﹤0.01% |
16,536
+607
| +4% | +$21.5K |
|
2183
Atara Biotherapeutics
ATRA
$75.5M
| $579K | ﹤0.01% |
1,128
+34
| +3% | +$14.1K |
|
|
PERY
2184
DELISTED
Perry Ellis International Inc
PERY
| $574K | ﹤0.01% |
26,730
+6,406
| +32% | +$148K |
|
|
XCRA
2185
DELISTED
Xcerra Corporation
XCRA
| $572K | ﹤0.01% |
64,310
+2,141
| +3% | +$17.7K |
|
|
SCNB
2186
DELISTED
Suffolk Bancorp
SCNB
| $572K | ﹤0.01% |
14,156
+974
| +7% | +$40.8K |
|
2187
Ennis
EBF
$552M
| $571K | ﹤0.01% |
33,580
+682
| +2% | +$11.3K |
|
2188
Kratos Defense & Security Solutions
KTOS
$8.74B
| $571K | ﹤0.01% |
73,423
+15,640
| +27% | +$125K |
|
|
CRR
2189
DELISTED
Carbo Ceramics Inc.
CRR
| $571K | ﹤0.01% |
43,809
+14,148
| +48% | +$181K |
|
|
BHBK
2190
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $571K | ﹤0.01% |
31,964
+3,353
| +12% | +$61.1K |
|
2191
Teekay
TK
$1.01B
| $570K | ﹤0.01% |
62,299
+3,177
| +5% | +$30.7K |
|
2192
Vicor
VICR
$9.56B
| $569K | ﹤0.01% |
35,325
+9,037
| +34% | +$139K |
|
|
PFC
2193
DELISTED
Premier Financial Corp. Common Stock
PFC
| $568K | ﹤0.01% |
22,944
+746
| +3% | +$18.3K |
|
2194
Waterstone Financial
WSBF
$370M
| $564K | ﹤0.01% |
30,911
+1,206
| +4% | +$22K |
|
|
DSPG
2195
DELISTED
DSP Group Inc
DSPG
| $564K | ﹤0.01% |
47,021
+11,871
| +34% | +$132K |
|
2196
Stagwell
STGW
$2.09B
| $557K | ﹤0.01% |
59,251
+2,337
| +4% | +$18.4K |
|
|
BGFV
2197
DELISTED
Big 5 Sporting Goods
BGFV
| $550K | ﹤0.01% |
36,440
+9,851
| +37% | +$150K |
|
|
CORR
2198
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $550K | ﹤0.01% |
16,282
+1,099
| +7% | +$38.4K |
|
2199
Celldex Therapeutics
CLDX
$2.99B
| $549K | ﹤0.01% |
10,147
+1,474
| +17% | +$76.8K |
|
2200
Par Pacific Holdings
PARR
$4.31B
| $548K | ﹤0.01% |
33,255
+966
| +3% | +$14.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.